Takeda Pharmaceutical (TAK) Construction in Progress (2017 - 2019)

Takeda Pharmaceutical's Construction in Progress history runs 3 years deep, the most recent figure standing at $88.9 million for Q1 2019.

• In Q1 2019, Construction in Progress changed N/A year-over-year to $88.9 million; the TTM figure through Mar 2019 stood at $88.9 million (changed N/A YoY), while the FY2019 annual figure was $88.9 million, changed N/A from the prior year.
• Construction in Progress was $88.9 million for Q1 2019 at Takeda Pharmaceutical, down from $1.0 billion in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $2.6 billion in Q4 2017 to a low of $88.9 million in Q1 2019.
• Historically, Construction in Progress has averaged $1.2 billion across 3 years, with a median of $1.0 billion in 2018.
• Biggest YoY gain for Construction in Progress was 60.76% in 2018; the steepest drop was 60.76% in 2018.
• A 3-year view of Construction in Progress shows it stood at $2.6 billion in 2017, then tumbled by 60.76% to $1.0 billion in 2018, then sank by 91.18% to $88.9 million in 2019.
• The last three Construction in Progress figures came in at $88.9 million (Q1 2019), $1.0 billion (Q4 2018), and $2.6 billion (Q4 2017), per Business Quant data.